Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart pain tracking may ease recovery after C-Sections

NCT ID NCT07720440

Symptom relief Sponsor: Istinye University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether a device that measures the body's pain signals during surgery can help doctors give just the right amount of pain medicine during C-sections. Sixty women having planned C-sections under general anesthesia will be randomly assigned to either standard monitoring or the Nociception Level Index-guided approach. The goal is to see if this leads to less pain after surgery, lower need for extra painkillers, and earlier first breastfeeding.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nociception Level Index Monitoring device used to guide fentanyl dosing during cesarean section
What this could lead to
If effective, this approach could offer better pain control after C-sections and faster recovery for new mothers.
What could go wrong
This is a small, early-stage trial with 60 participants. The device may not improve pain outcomes over standard care, and results may not apply to all C-sections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Aug 2023

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients undergoing elective cesarean section under general anesthesia. * Ability to provide written informed consent. Exclusion Criteria: * Refusal to participate. * Emergency cesarean section. * High-risk pregnancy (including hypertensive disorders of pregnancy, diabetes mellitus, preterm labor, or fetal growth restriction). * Placental abnormalities. * History of allergy to any study medication. * History of malignant hyperthermia. * Alcohol or substance abuse. * Severe cardiac disease or severe arrhythmia. * Peripheral vascular disease. * Renal or hepatic failure. * Contraindication to corticosteroid administration.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean section are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Breast Feeding Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean section Pain management Postoperative pain after cesarean section

Contacts and locations

Locations

  • University of Health Sciences Türkiye Haseki Training and Research Hospital

    Istanbul, Sultangazi, 34256, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.